Efficacy of disease-modifying therapies in relapsing remitting multiple sclerosis: a systematic comparison.
about
Information provision for people with multiple sclerosisInformation provision for persons with multiple sclerosisNatalizumab for relapsing remitting multiple sclerosisPatients' and observers' perceptions of involvement differ. Validation study on inter-relating measures for shared decision makingNeuroimaging in multiple sclerosis: neurotherapeutic implications.Impact of exposure to interferon beta-1a on outcomes in patients with relapsing-remitting multiple sclerosis: exploratory analyses from the PRISMS long-term follow-up studyDisease-modifying drugs for multiple sclerosis in pregnancy: a systematic review.Mental toughness, sleep disturbances, and physical activity in patients with multiple sclerosis compared to healthy adolescents and young adultsImmunotherapy of autoimmunity and cancer: the penalty for success.Treatment of walking impairment in multiple sclerosis: an unmet need for a disease-specific disability.The present efficacy of multiple sclerosis therapeutics: Is the new 66% just the old 33%?Autologous hematopoietic stem cell transplantation as a treatment option for aggressive multiple sclerosis.Mass spectrometry measurement of a therapeutic peptide for use in multiple sclerosis.Oral teriflunomide in the treatment of relapsing forms of multiple sclerosis: clinical evidence and long-term experience.Escalation to natalizumab or switching among immunomodulators in relapsing multiple sclerosis.
P2860
Q24195040-4417E158-F204-4F03-BE99-9F7E53559F0CQ24235042-0015984B-FDD2-4F0D-84BF-1C297F3795FAQ24235861-0BBA527B-F4A8-4063-A88F-A58265740A87Q28743745-6846AB8A-C994-4E8E-9939-BCF2B5F1D207Q33806032-4364AAF7-2FEE-4902-B955-E0C6971F8DE6Q34565669-0613674A-C3C8-499B-BCE7-E0BDEFE39BB0Q36475245-85266471-B4AC-4981-A38D-77175AD17325Q37058811-FE85358B-1E24-4D24-B9C0-F69FF48EAD18Q37325451-EC7B01A8-8D07-449A-AB0D-A56F1738BB97Q37884071-787A5F4F-263A-442D-9BD0-B2B86FC4417AQ42573163-0B055547-D519-45FC-8F28-C8A6DD8D407CQ44621693-53772712-432D-4D64-8AC8-454EC95244B3Q45858747-DDEBCE96-E759-4682-B490-120E27ADCCE5Q47105088-6404B1D6-E5E6-4F8D-919E-938F994A4EA7Q48956772-BCD88FD8-DD57-43EA-B9EC-741040D59B0E
P2860
Efficacy of disease-modifying therapies in relapsing remitting multiple sclerosis: a systematic comparison.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 25 April 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Efficacy of disease-modifying ...... osis: a systematic comparison.
@en
Efficacy of disease-modifying ...... osis: a systematic comparison.
@nl
type
label
Efficacy of disease-modifying ...... osis: a systematic comparison.
@en
Efficacy of disease-modifying ...... osis: a systematic comparison.
@nl
prefLabel
Efficacy of disease-modifying ...... osis: a systematic comparison.
@en
Efficacy of disease-modifying ...... osis: a systematic comparison.
@nl
P2093
P356
P1433
P1476
Efficacy of disease-modifying ...... osis: a systematic comparison.
@en
P2093
Ahmad Al-Sabbagh
Brian Cuffel
Bruce Hughes
Daniel D Mikol
Mark S Freedman
Nicole LaVallee
Randy Bennett
Vamil Divan
P356
10.1159/000127972
P577
2008-04-25T00:00:00Z